$PCRX
Pacira BioSciences, Inc.

2024 Q4 Form 10-Q Financial Statement

#000139681424000141 Filed on November 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $168.6M
YoY Change 2.83%
Cost Of Revenue $38.86M
YoY Change -2.23%
Gross Profit $129.7M
YoY Change 4.46%
Gross Profit Margin 76.95%
Selling, General & Admin $74.33M
YoY Change 9.4%
% of Gross Profit 57.31%
Research & Development $19.10M
YoY Change -8.29%
% of Gross Profit 14.73%
Depreciation & Amortization $6.000M
YoY Change 46.34%
% of Gross Profit 4.63%
Operating Expenses $93.44M
YoY Change 5.25%
Operating Profit -$139.5M
YoY Change -887.35%
Interest Expense $793.0K
YoY Change -77.11%
% of Operating Profit
Other Income/Expense, Net $671.0K
YoY Change -159.91%
Pretax Income -$138.9M
YoY Change -936.43%
Income Tax $4.610M
% Of Pretax Income
Net Earnings -$143.5M
YoY Change -1421.29%
Net Earnings / Revenue -85.11%
Basic Earnings Per Share -$3.11
Diluted Earnings Per Share -$3.11
COMMON SHARES
Basic Shares Outstanding 46.17M shares 46.13M shares
Diluted Shares Outstanding 46.13M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $453.8M
YoY Change 92.95%
Cash & Equivalents $246.0M
Short-Term Investments $207.8M
Other Short-Term Assets $23.64M
YoY Change 27.1%
Inventory $111.9M
Prepaid Expenses
Receivables $100.7M
Other Receivables $0.00
Total Short-Term Assets $690.0M
YoY Change 54.27%
LONG-TERM ASSETS
Property, Plant & Equipment $166.9M
YoY Change -5.08%
Goodwill $0.00
YoY Change -100.0%
Intangibles $440.3M
YoY Change -11.51%
Long-Term Investments $36.73M
YoY Change 3.45%
Other Assets $134.0M
YoY Change -11.65%
Total Long-Term Assets $831.7M
YoY Change -23.5%
TOTAL ASSETS
Total Short-Term Assets $690.0M
Total Long-Term Assets $831.7M
Total Assets $1.522B
YoY Change -0.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $19.37M
YoY Change 17.3%
Accrued Expenses $76.38M
YoY Change 27.54%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $201.5M
YoY Change 2242.63%
Total Short-Term Liabilities $306.4M
YoY Change 227.14%
LONG-TERM LIABILITIES
Long-Term Debt $385.9M
YoY Change -25.2%
Other Long-Term Liabilities $12.78M
YoY Change 7.02%
Total Long-Term Liabilities $12.78M
YoY Change 7.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $306.4M
Total Long-Term Liabilities $12.78M
Total Liabilities $772.1M
YoY Change 9.84%
SHAREHOLDERS EQUITY
Retained Earnings -$222.4M
YoY Change 68.91%
Common Stock $47.00K
YoY Change 2.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $749.6M
YoY Change
Total Liabilities & Shareholders Equity $1.522B
YoY Change -0.83%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$143.5M
YoY Change -1421.29%
Depreciation, Depletion And Amortization $6.000M
YoY Change 46.34%
Cash From Operating Activities $53.92M
YoY Change 21.17%
INVESTING ACTIVITIES
Capital Expenditures $4.092M
YoY Change 20.35%
Acquisitions
YoY Change
Other Investing Activities -$48.07M
YoY Change 4707.1%
Cash From Investing Activities -$52.16M
YoY Change 1113.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.845M
YoY Change -89.77%
NET CHANGE
Cash From Operating Activities 53.92M
Cash From Investing Activities -52.16M
Cash From Financing Activities -2.845M
Net Change In Cash -1.088M
YoY Change -108.77%
FREE CASH FLOW
Cash From Operating Activities $53.92M
Capital Expenditures $4.092M
Free Cash Flow $49.83M
YoY Change 21.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Registrant Name
EntityRegistrantName
PACIRA BIOSCIENCES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
51-0619477
dei Entity Address City Or Town
EntityAddressCityOrTown
Tampa
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33609
dei City Area Code
CityAreaCode
813
dei Local Phone Number
LocalPhoneNumber
553-6680
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
PCRX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
46173240 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
245965000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
153298000 usd
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
207845000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
100653000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
105556000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
111865000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
104353000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23641000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
21504000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
689969000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
509994000 usd
CY2024Q3 us-gaap Long Term Investments
LongTermInvestments
0 usd
CY2023Q4 us-gaap Long Term Investments
LongTermInvestments
2410000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
166852000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
173927000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
53830000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
61020000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
64243000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9191000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8801000 usd
CY2024Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
201466000 usd
CY2024Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
201466000 usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
8641000 usd
CY2023Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
8641000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
168573000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
163926000 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
38864000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
39750000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19104000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20830000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
74333000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
67947000 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14322000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14322000 usd
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.11
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
749583000 usd
us-gaap Net Income Loss
NetIncomeLoss
-115601000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-5541000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4903000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7512000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6338000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3409000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
12546000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1195000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
156257000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8518000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
207017000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
132627000 usd
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
6758000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
69167000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1939000 usd
pcrx Proceeds From Shares Issued Under Employee Stock Purchase Plans
ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans
1672000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001396814
dei Entity Address Address Line1
EntityAddressAddressLine1
5401 West Kennedy Boulevard, Suite 890
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
125283000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
0 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
440292000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
483258000 usd
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
134022000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
144485000 usd
CY2024Q3 pcrx Equity Method Investments And Other Assets
EquityMethodInvestmentsAndOtherAssets
36726000 usd
CY2023Q4 pcrx Equity Method Investments And Other Assets
EquityMethodInvestmentsAndOtherAssets
36049000 usd
CY2024Q3 us-gaap Assets
Assets
1521691000 usd
CY2023Q4 us-gaap Assets
Assets
1574386000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
19367000 usd
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46481174 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46481174 shares
us-gaap Investment Income Interest
InvestmentIncomeInterest
8019000 usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
7518000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-16926000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-122000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-422000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-320000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
671000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1120000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-138856000 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0 usd
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
9350000 usd
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
1163000 usd
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q4 us-gaap Goodwill
Goodwill
163243000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
15698000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
76377000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
306401000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
97383000 usd
CY2024Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
278867000 usd
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
398594000 usd
CY2024Q3 us-gaap Secured Long Term Debt
SecuredLongTermDebt
107024000 usd
CY2023Q4 us-gaap Secured Long Term Debt
SecuredLongTermDebt
115202000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
47875000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
54806000 usd
CY2024Q3 pcrx Contingent Consideration Noncurrent
ContingentConsiderationNoncurrent
19157000 usd
CY2023Q4 pcrx Contingent Consideration Noncurrent
ContingentConsiderationNoncurrent
24698000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
12784000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13573000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
772108000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
704256000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46985386 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46148146 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
47000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
46000 usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
837240 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
0 shares
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
0 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
996376000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
976633000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-222397000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-106796000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
678000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
247000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
749583000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
870130000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1521691000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1574386000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
513713000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
493734000 usd
us-gaap Cost Of Revenue
CostOfRevenue
130542000 usd
us-gaap Cost Of Revenue
CostOfRevenue
136977000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
57680000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
56794000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
214485000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
203640000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
42966000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
42966000 usd
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
1900000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
10818000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
1345000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
1444000 usd
us-gaap Sublease Income
SubleaseIncome
248000 usd
us-gaap Sublease Income
SubleaseIncome
489000 usd
us-gaap Lease Cost
LeaseCost
11513000 usd
us-gaap Lease Cost
LeaseCost
11773000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
43000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
43000000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
11404000 usd
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
16670000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2311000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
70000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
728000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1869000 usd
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
2791000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
11889000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
16918000 usd
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0300
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0396
CY2024Q3 us-gaap Share Price
SharePrice
15.05
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
25121000 usd
CY2024Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
163243000 usd
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
163243000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2024Q3 pcrx Contingent Consideration Gain Loss Restructuring Charges And Other
ContingentConsiderationGainLossRestructuringChargesAndOther
1766000 usd
CY2023Q3 pcrx Contingent Consideration Gain Loss Restructuring Charges And Other
ContingentConsiderationGainLossRestructuringChargesAndOther
-3356000 usd
pcrx Contingent Consideration Gain Loss Restructuring Charges And Other
ContingentConsiderationGainLossRestructuringChargesAndOther
-2872000 usd
pcrx Contingent Consideration Gain Loss Restructuring Charges And Other
ContingentConsiderationGainLossRestructuringChargesAndOther
1150000 usd
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
308100000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
146205000 usd
us-gaap Costs And Expenses
CostsAndExpenses
611788000 usd
us-gaap Costs And Expenses
CostsAndExpenses
439227000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-139527000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
17721000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-98075000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
54507000 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
5482000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2766000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
14134000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
4689000 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
3464000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
11889000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
16918000 usd
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-701000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9443000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-26526000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16601000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-88632000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
27981000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4610000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5743000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26969000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10896000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-143466000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
10858000 usd
us-gaap Net Income Loss
NetIncomeLoss
-115601000 usd
us-gaap Net Income Loss
NetIncomeLoss
17085000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.11
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.50
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.50
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46134000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46416000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46269000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46151000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46134000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52067000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46269000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46343000 shares
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-143466000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
10858000 usd
us-gaap Net Income Loss
NetIncomeLoss
-115601000 usd
us-gaap Net Income Loss
NetIncomeLoss
17085000 usd
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
597000 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
146000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
437000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
362000 usd
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-24000 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
17000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-6000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
8000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
573000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
163000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
431000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
370000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-142893000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11021000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-115170000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
17455000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
879278000 usd
CY2024Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
32000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13230000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
573000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-143466000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
807975000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
25000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12530000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
163000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
10858000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
831551000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
870130000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
1000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
414000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1364000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
38905000 usd
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
25121000 usd
pcrx Adjustments To Additional Paid In Capital Purchase Of Capped Calls Net Of Tax
AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallsNetOfTax
20112000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
431000 usd
us-gaap Net Income Loss
NetIncomeLoss
-115601000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
749583000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
775010000 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1939000 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1672000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
35475000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
370000 usd
us-gaap Net Income Loss
NetIncomeLoss
17085000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
831551000 usd
us-gaap Net Income Loss
NetIncomeLoss
17085000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
163243000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
17113000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
9014000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
57542000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
57089000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2284000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2311000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
70000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
728000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
7518000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-16926000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
38905000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
35475000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-3847000 usd
us-gaap Provision For Other Losses
ProvisionForOtherLosses
-53000 usd
us-gaap Provision For Other Losses
ProvisionForOtherLosses
2415000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1440000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
457000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6986000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1988000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-26156000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
40000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
107065000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13363000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
111682000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
200970000 usd
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-82908000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
pcrx Proceeds From Shares Issued Under Employee Stock Purchase Plans
ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlans
1364000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
414000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
25000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
287500000 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
149550000 usd
us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
26709000 usd
us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
0 usd
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
5750000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19318000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-181252000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
92667000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5020000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
153298000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
104139000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
245965000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99119000 usd
us-gaap Interest Paid Net
InterestPaidNet
10191000 usd
us-gaap Interest Paid Net
InterestPaidNet
24931000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9575000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2072000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
415000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1470000 usd
CY2024Q3 us-gaap Share Repurchase Program Excise Tax Payable
ShareRepurchaseProgramExciseTaxPayable
121000 usd
CY2023Q3 us-gaap Share Repurchase Program Excise Tax Payable
ShareRepurchaseProgramExciseTaxPayable
0 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
52533000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
54099000 usd
CY2024Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
23100000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
31215000 usd
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
36232000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
19039000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
111865000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
104353000 usd
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
296579000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
309233000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
129727000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
135306000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
166852000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
173927000 usd
CY2024Q3 us-gaap Depreciation
Depreciation
6000000.0 usd
CY2023Q3 us-gaap Depreciation
Depreciation
4100000 usd
CY2024Q3 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
500000 usd
CY2023Q3 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
700000 usd
us-gaap Depreciation
Depreciation
14600000 usd
us-gaap Depreciation
Depreciation
14100000 usd
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
2800000 usd
CY2024Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
4100000 usd
CY2023Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
4300000 usd
CY2024Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2024Q3 pcrx Number Of Leases
NumberOfLeases
2 lease
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
3459000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
3559000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
10416000 usd
CY2024Q3 us-gaap Variable Lease Cost
VariableLeaseCost
562000 usd
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
499000 usd
CY2024Q3 us-gaap Sublease Income
SubleaseIncome
56000 usd
CY2023Q3 us-gaap Sublease Income
SubleaseIncome
167000 usd
CY2024Q3 us-gaap Lease Cost
LeaseCost
3965000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
3891000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
9686000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
11055000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y4M9D
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y3M3D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0699
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0703
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3264000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
12788000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
12823000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
12587000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
10924000 usd
CY2024Q3 pcrx Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
16426000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
68812000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
11746000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
57066000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
163200000 usd
CY2024Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
163200000 usd
CY2024Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
590090000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
184664000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
405426000 usd
CY2024Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
624956000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
184664000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
440292000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
590090000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
141698000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
448392000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
624956000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
141698000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
483258000 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14300000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14300000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
14300000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
57300000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
57300000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
57300000 usd
CY2024Q3 pcrx Finite Lived Intangible Asset Expected Amortization Year Six
FiniteLivedIntangibleAssetExpectedAmortizationYearSix
57300000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
57300000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
57300000 usd
CY2024Q3 pcrx Finite Lived Intangible Asset Expected Amortization Year Seven
FiniteLivedIntangibleAssetExpectedAmortizationYearSeven
37400000 usd
CY2024Q3 pcrx Finite Lived Intangible Asset Expected Amortization Year Eight
FiniteLivedIntangibleAssetExpectedAmortizationYearEight
7900000 usd
CY2024Q3 pcrx Finite Lived Intangible Asset Expected Amortization Year Nine
FiniteLivedIntangibleAssetExpectedAmortizationYearNine
2200000 usd
CY2024Q2 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
150000000 usd
CY2024Q2 us-gaap Share Price
SharePrice
29.86
CY2024Q2 us-gaap Share Price
SharePrice
29.86
CY2024Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
4296000 usd
CY2023Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
3471000 usd
CY2024Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
840000 usd
CY2023Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
683000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2284000 usd
CY2024Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
23000 usd
CY2023Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
25000 usd
CY2024Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
470000 usd
CY2023Q3 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
715000 usd
CY2024Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
4689000 usd
CY2023Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
3464000 usd
CY2024Q3 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0303
CY2023Q3 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.0298
CY2024Q3 us-gaap Share Price
SharePrice
15.05
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
21192000 usd
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
6758000 usd
CY2023 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
61000 usd
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
28011000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
23000 usd
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
28034000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
207400000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
465000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
20000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
127631000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
111000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
49000 usd
CY2024Q3 us-gaap Interest Receivable
InterestReceivable
300000 usd
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
400000 usd
pcrx Number Of Major Customers
NumberOfMajorCustomers
3 wholesaler
CY2023 pcrx Number Of Major Customers
NumberOfMajorCustomers
3 wholesaler
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-100000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
200000 usd
CY2024Q2 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
150000000 usd
CY2024Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
837240 shares
CY2024Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
25100000 usd
CY2024Q2 pcrx Accrued Excise Tax On Treasury Stock
AccruedExciseTaxOnTreasuryStock
100000 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13230000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12530000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
38905000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
35475000 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13230000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12530000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
38905000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
35475000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7079748 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
49.40
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1164323 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
30.87
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
240232 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
45.52
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1108285 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
61.72
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6895554 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.42
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.13
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.85
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
56077 shares
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-143466000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
10858000 usd
us-gaap Net Income Loss
NetIncomeLoss
-115601000 usd
us-gaap Net Income Loss
NetIncomeLoss
17085000 usd
CY2024Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-143466000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
11887000 usd
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-115601000 usd
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
17085000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46134000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46416000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46269000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46151000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46134000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
52067000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46269000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46343000 shares
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.11
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.11
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.50
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.50
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.37
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12430000 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8445000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13475000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12530000 shares
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-140309000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
16631000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-89656000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
29047000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
1453000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-30000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
1024000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-1066000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-138856000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16601000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-88632000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
27981000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4610000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5743000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26969000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10896000 usd
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.03
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.35
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.30
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.39
CY2023Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
1000000 usd
CY2024Q3 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
1000000 usd
CY2024Q3 us-gaap Restructuring Charges
RestructuringCharges
1193000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
173000 usd
us-gaap Restructuring Charges
RestructuringCharges
7724000 usd
us-gaap Restructuring Charges
RestructuringCharges
1109000 usd
CY2024Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
285000 usd
CY2023Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
390000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
689000 usd
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1588000 usd
CY2024Q3 pcrx Contingent Consideration Gain Loss Restructuring Charges And Other
ContingentConsiderationGainLossRestructuringChargesAndOther
1766000 usd
CY2023Q3 pcrx Contingent Consideration Gain Loss Restructuring Charges And Other
ContingentConsiderationGainLossRestructuringChargesAndOther
-3356000 usd
pcrx Contingent Consideration Gain Loss Restructuring Charges And Other
ContingentConsiderationGainLossRestructuringChargesAndOther
-2872000 usd
pcrx Contingent Consideration Gain Loss Restructuring Charges And Other
ContingentConsiderationGainLossRestructuringChargesAndOther
1150000 usd
CY2024Q3 us-gaap Restructuring Charges
RestructuringCharges
1200000 usd
us-gaap Restructuring Charges
RestructuringCharges
7700000 usd
CY2023Q3 us-gaap Restructuring Charges
RestructuringCharges
200000 usd
us-gaap Restructuring Charges
RestructuringCharges
1100000 usd
CY2023Q3 pcrx Litigation Settlement Amount Expected To Be Awarded From Other Party
LitigationSettlementAmountExpectedToBeAwardedFromOtherParty
14500000 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001396814-24-000141-index-headers.html Edgar Link pending
0001396814-24-000141-index.html Edgar Link pending
0001396814-24-000141.txt Edgar Link pending
0001396814-24-000141-xbrl.zip Edgar Link pending
ex106-ar2014inducementplan.htm Edgar Link pending
ex107-ar2014inducementplan.htm Edgar Link pending
ex108-ar2014inducementplan.htm Edgar Link pending
exhibit103-laurenrikeramen.htm Edgar Link pending
exhibit104-laurenrikeramen.htm Edgar Link pending
exhibit105-charlesareinhar.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pcrx-20240930.htm Edgar Link pending
pcrx-20240930.xsd Edgar Link pending
pcrx-20240930_g1.jpg Edgar Link pending
pcrx-20240930_g2.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pcrx-20240930_cal.xml Edgar Link unprocessable
pcrx-20240930_def.xml Edgar Link unprocessable
pcrx-20240930_lab.xml Edgar Link unprocessable
pcrx-20240930_htm.xml Edgar Link completed
pcrx-9302024xex311.htm Edgar Link pending
pcrx-9302024xex312.htm Edgar Link pending
pcrx-9302024xex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pcrx-20240930_pre.xml Edgar Link unprocessable